Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1

Interventions

Temozolomide 23Radiotherapy 10Magnetic Resonance Spectroscopy 10Radiation 8Specimen Handling 7Lomustine 4Bevacizumab 4Nivolumab 3Biopsy 3veliparib 2trametinib 2olaparib 2lutetium Lu 177 dotatate 2dabrafenib 2cemiplimab 2azeliragon 2Surgical Procedures, Operative 2Receptors, Interleukin-8B 2Photons 2Palliative Care 2Ipilimumab 2D2C7-(scdsFv)-PE38KDEL 2CTLA-4 Antigen 2Aminolevulinic Acid 2vocimagene amiretrorepvec 1varlilumab 1ulixertinib 1tinostamustine 1temsirolimus 1senicapoc 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × 1-phenyl-3,3-dimethyltriazene × 30 days × Clear all
NCT05736406 2026-05-22

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Hemerion Therapeutics

Phase 1/2 Active not recruiting
12 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡